Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite extensive reports of the benefits of statins in reducing serious cardiovascular events such as stroke and heart disease in patients with elevated LDL-cholesterol, patients do not take their medicines regularly as prescribed. Reasons include forgetfulness, lack of understanding of the seriousness of the disease, and fear of side effects. An intervention strategy comprising 3-5 minutes of counseling, emotional support and cost-sharing may be motivational and improve adherence to treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Compliance With Treatment For Patients With Hyperlipidemia

NCT00828945

Hyperlipidemia

COMPLETED

Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels

NCT00143234

Hypertension Hyperlipidemia

COMPLETED PHASE3

Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes

NCT00299169

Diabetes Cardiovascular Disease Hyperlipidemia

TERMINATED PHASE4

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

NCT00530946

Hypertension Hypercholesterolemia

COMPLETED PHASE3

Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

NCT00137462

Hyperlipidemia

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Medication Non-Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

No Patient Counseling

Intervention Type BEHAVIORAL

Patients do not receive any adherence counseling, or other patient support services

Intervention Arm

Adherence Counseling

Intervention Type BEHAVIORAL

Patients receive 3-5 minutes of adherence counseling, and other patient support services

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Patient Counseling

Patients do not receive any adherence counseling, or other patient support services

Intervention Type BEHAVIORAL

Adherence Counseling

Patients receive 3-5 minutes of adherence counseling, and other patient support services

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female aged \>21 years
* Have received a new or re-fil prescription for atorvastatin at first study visit to Prairie Heart Institute
* Signed informed consent

Exclusion Criteria

* Unwilling to give written informed consent
* Failed statin treatment in the past
* Switched from another statin to atorvastatin because of co-pay program
* Participated in an earlier Market Research study on Impact of cholesterol management behaviors post in-clinic adherence intervention

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No